Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Ardelyx reports data for RDX-022 in the treatment of hyperkalemia

Jan. 7, 2016

Lundbeck reports PDE9 inhibitors

Dec. 28, 2015

Astellas Pharma patents muscarinic M3 receptor PAMs

Dec. 24, 2015

Astellas Pharma and Kotobuki Pharmaceutical present IRAP and P-LAP inhibitors

Dec. 22, 2015

DMX-200 drug combination given FDA orphan designation for focal segmental glomerulosclerosis

Dec. 15, 2015

University of California, Oakland divulges UT-A inhibitors

Nov. 26, 2015

BTK inhibition, a potential strategy for the treatment of lupus nephritis

Nov. 26, 2015

Angion's CYP11B2 inhibitor shows potential for CKD in animal models

Nov. 25, 2015

FDA grants orphan drug designation to Amyndas Pharmaceuticals' Compstatin 40

Nov. 18, 2015

ProMetic reveals agent under development for diabetic nephropathy

Nov. 18, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...